This list is an analysis based on recent market events. It's not an investment recommendation.
About
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
The current price of 6926.TWO is TWD59.50 TWD — it has decreased by -1.65% in the past 24 hours. Watch Shine-On BioMedical stock price performance more closely on the chart.
What is Shine-On BioMedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Shine-On BioMedical stocks are traded under the ticker 6926.TWO.
Is Shine-On BioMedical stock price growing?▼
6926.TWO stock has fallen by -7.03% compared to the previous week, the month change is a -11.46% fall, over the last year Shine-On BioMedical has showed a -14.76% decrease.
What is Shine-On BioMedical market cap?▼
Today Shine-On BioMedical has the market capitalization of 2.96B
What is Shine-On BioMedical revenue for the last year?▼
Shine-On BioMedical revenue for the last year amounts to 30M TWD.
What is Shine-On BioMedical net income for the last year?▼
6926.TWO net income for the last year is -110.29M TWD.
How many employees does Shine-On BioMedical have?▼
As of November 3, 2026, the company has 22 employees.
In which sector is Shine-On BioMedical located?▼
Shine-On BioMedical operates in the Health & Wellness sector.
When did Shine-On BioMedical complete a stock split?▼
Shine-On BioMedical has not had any recent stock splits.
Where is Shine-On BioMedical headquartered?▼
Shine-On BioMedical is headquartered in Taichung, Taiwan.